Search clinical trials for: antiplatelet agents(Clopidogrel or Ticagrelor)

Total 3955 results

The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
Hospital Álvaro Cunqueiro

Unknown

Registry of Acute Coronary Syndrome From University Hospital of Vigo (CardioCHUVI)

Acute Coronary Syndrome

Spain
Yonsei University

Not yet recruiting

24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

High Ischemic Risk

Korea, Republic of
University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
Faculty Hospital Kralovske Vinohrady

Completed

The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry (LAPCOR)

Platelet Aggregation Onhibitors

Czechia
National Institute of Cardiovascular Diseases,...
PharmEvo Pvt Ltd

Recruiting

TADCLOT- a Double Blind Randomized Controlled Trial (TADCLOT)

Stent Thrombosis | Myocardial Infarction, Acute

Pakistan
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Xuanwu Hospital, Beijing

Recruiting

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis (VISTA)

Ischemic Stroke | Vertebral Artery Stenosis

China
Harbin Medical University
LanZhou University; Hebei General Hospital; The First Hospital of Jilin University and other collaborators

Active, not recruiting

EROSION II: OCT Guided PPCI in STEMI

ST-segment Elevation Myocardial Infarction

China
Imam Abdulrahman Bin Faisal University
King Fahad Armed Forces Hospital; Dammam Central Hospital

Unknown

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

Myocardial Infarction | Infarction | Ischemia | Coronary Artery Disease | Cardiovascular Disease | Embolism | Thrombosis | Chest Pain | Angina Pectoris | Heart Disease | Vascular Disease

Saudi Arabia
HonorHealth Research Institute
Boston Scientific Corporation

Active, not recruiting

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy (SYNIVUS-DAPT)

Coronary Artery Disease | Atherosclerosis | Stent Placement

United States
Second Affiliated Hospital, School of Medicine,...

Completed

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Coronary Heart Disease

China
Chinese PLA General Hospital

Unknown

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS (GI-CT)

CLOPIDOGREL, POOR METABOLISM of (Disorder)

China
Ludwig-Maximilians - University of Munich

Recruiting

Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI (EPIDAURUS)

Atrial Fibrillation | Acute Coronary Syndrome

Germany
Seung-Jung Park
Roche Pharma AG; AstraZeneca; KBM pharm

Completed

Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes (OPTIMA)

Acute Coronary Syndrome

Korea, Republic of
First Affiliated Hospital of Harbin Medical University

Unknown

Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease

Coronary Artery Disease

United States, China
Zunyi Medical College

Recruiting

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

STEMI - ST Elevation Myocardial Infarction

China
University of Patras

Completed

Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.

Platelet Reactivity

Greece
Wroclaw Medical University

Recruiting

Effects of P2Y12 Receptor Inhibitors on Central and Peripheral Chemoreceptors' Sensitivity

Dyspnea

Poland
First Affiliated Hospital of Harbin Medical University
RenJi Hospital; Shengjing Hospital; Beijing Anzhen Hospital; Shaanxi Provincial... and other collaborators

Completed

Efficacy and Safety of Low-dose Ticagrelor

Coronary Artery Disease

China
Fundación Investigación Sanitaria en León
AstraZeneca

Completed

EndoTic - Endothelium and Ticagrelor

Acute Coronary Syndrome (ACS)

Spain
Ajou University School of Medicine

Completed

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel (CABG)

Blood Loss, Surgical | Ticagrelor | Clopidogrel

Korea, Republic of
Kyunghee University Medical Center
Kyunghee University

Completed

ONSET and OFFSET of Ticagrelor in ESRD

Chronic Kidney Disease

Korea, Republic of
First Affiliated Hospital of Harbin Medical University

Unknown

Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease

Coronary Artery Disease

United States
Brigham and Women's Hospital

Completed

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
University Medical Centre Ljubljana

Completed

Antiplatelet Therapy After Cardiac Arrest

Cardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)

Slovenia
St. Antonius Hospital
UMC Utrecht; Leiden University Medical Center; Medical Centre Leeuwarden; Rijnstate... and other collaborators

Unknown

Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly (POPular AGE)

Unstable Angina | Non-ST-elevation Acute Coronary Syndrome | Non-ST-elevation Myocardial Infarction

Netherlands
Kaiser Franz Josef Hospital

Completed

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry (IDEAL-PCI)

Coronary Stent Implantation | Platelet Inhibition

Austria
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
First Affiliated Hospital of Harbin Medical University

Completed

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Platelet Reactivity

China
AstraZeneca

Terminated

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin. (NSTE-ACS)

Non-ST Elevation Acute Coronary Syndrome

United States
Beijing Anzhen Hospital

Recruiting

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

Angina, Stable | Acute Coronary Syndrome | Drug-Eluting Stents | Genotype

China
AstraZeneca

Withdrawn

A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient

Coronary Heart Disease
Dong-A University

Recruiting

Optimal Dosage of Ticagrelor in Korean Patients With AMI

Acute Myocardial Infarction | Ticagrelor

Korea, Republic of
First Affiliated Hospital of Harbin Medical University

Unknown

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

Platelet Reactivity

China
Beijing Anzhen Hospital

Unknown

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention (LOTIC)

Coronary Artery Disease | Percutaneous Coronary Intervention | Antiplatelet Therapy

China
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
The First Affiliated Hospital with Nanjing Medical...

Unknown

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Acute Coronary Syndrome (ACS)

China
University of Patras

Completed

Effect of Ticagrelor on Fractional Flow Reserve

Fractional Flow Reserve

Greece
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Thrombosis

China
Ping-Yen Liu

Unknown

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients (APROVE-CKD)

Chronic Kidney Disease | Acute Coronary Syndrome | End-Stage Renal Disease

Taiwan
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients (PANDDA)

Diabetes

Canada
Samsung Medical Center

Unknown

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE) (SMART-DATE)

Acute Coronary Syndrome

Korea, Republic of
Boston Scientific Corporation

Active, not recruiting

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Stroke

United States, Denmark, Germany, Netherlands, United Kingdom, Belgium, Canada, Czechia, Italy
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers

Healthy

China
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting (ATCCC)

Antiplatelet Therapy of Coronary Artery Bypass

China
Seoul National University Hospital
Hanyang University; Kangbuk Samsung Hospital; Keimyung University Dongsan Medical... and other collaborators

Recruiting

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)

Coronary Artery Disease

Korea, Republic of
The First Affiliated Hospital with Nanjing Medical...

Unknown

Effect of Haemodialysis on the Efficacy of Antiplatelet Agents

Coronary Artery Disease | Renal Failure | Hemolysis

China
Hospital Israelita Albert Einstein

Recruiting

Platelet Sub-study of the Neomindset Trial

Acute Coronary Syndrome

Brazil
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Not yet recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome (ADEN)

MYOCARDIAL INFARCTION

France

Search clinical trials for: antiplatelet agents(Clopidogrel or Ticagrelor)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations